Fora Capital, LLC Gsk PLC Transaction History

Fora Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$38.88 - $45.31 $342,027 - $398,592	-8,797 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $341,235 - $379,678	8,797 New	8,797 $336,000
Q3 2020 Nov 13, 2020	SELL	$38.11 - $42.99 $100,343 - $113,192	-2,633 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $1.74 Million - $2.01 Million	-46,031 Reduced 94.59%	2,633 $107 Million
Q1 2020 May 15, 2020	BUY	$32.47 - $48.83 $812,886 - $1.22 Million	25,035 Added 105.95%	48,664 $1.88 Million
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $992,418 - $1.14 Million	23,629 New	23,629 $1.13 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $76.7B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.